Insiders Trades

★ Sign in to follow

HM

Harold Morton Wolkin

Cipher Pharmaceuticals Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 1 saleApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

98

Company

1

▲ Purchases (5 ops.)

€403k

▼ Sales (2 ops.)

€61k

Latest filing published 15 Sept 2025 for Cipher Pharmaceuticals Inc., €76k. Read the official filing

Filing timeline

BuySale

Harold Morton Wolkin

Insider track record

Disclosed buys

5

Disclosed sells

2

Signal history

Harold Morton Wolkin: trading record in brief

This profile gathers the share dealings of Harold Morton Wolkin in Cipher Pharmaceuticals Inc. Over a trading history stretching from 8 August 2016 to 11 September 2025, the count stands at 98 filings.

Both buying and selling appear: 5 purchases worth €403k, against 2 sales worth €61k. Purchases outweigh sales by €342k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 81 share grants and 9 option exercises. So far in 2025, the count stands at no purchases and 2 sales.

The median purchase comes to €85k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

The record was last updated on 15 September 2025 with an option exercise (€76k) in Cipher Pharmaceuticals Inc. The most recent open-market purchase was published on 23 March 2018, 3,134 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Harold Morton Wolkin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cipher Pharmaceuticals Inc. (CA)

Declarations97 total

◇

Harold Morton Wolkin

4 - Director of IssuerExecutives11 Sept 2025Cipher Pharmaceuticals Inc.

122,700 CAD14SEDI ↗

7,500 shares@ CA$16.3626.0% of flowCommon SharesTSXSEDI:4575426

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Aug 2025Cipher Pharmaceuticals Inc.

5,486 CAD17SEDI ↗

365 shares@ CA$15.030.6% of flowCommon SharesTSXSEDI:4562481

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Jul 2025Cipher Pharmaceuticals Inc.

5,520 CAD17SEDI ↗

422 shares@ CA$13.080.6% of flowCommon SharesTSXSEDI:4548441

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives16 Jun 2025Cipher Pharmaceuticals Inc.

4,673 CAD17SEDI ↗

360 shares@ CA$12.980.5% of flowCommon SharesTSXSEDI:4530292

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives16 May 2025Cipher Pharmaceuticals Inc.

4,677 CAD15SEDI ↗

362 shares@ CA$12.920.5% of flowCommon SharesTSXSEDI:4513780

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Apr 2025Cipher Pharmaceuticals Inc.

4,669 CAD13SEDI ↗

411 shares@ CA$11.360.5% of flowCommon SharesTSXSEDI:4499094

◇

Harold Morton Wolkin

4 - Director of IssuerExecutives24 Mar 2025Cipher Pharmaceuticals Inc.

12,355 CAD13SEDI ↗

3,500 shares@ CA$3.531.4% of flowCommon SharesTSXSEDI:4479656

▼

Harold Morton Wolkin

4 - Director of IssuerExecutives24 Mar 2025Cipher Pharmaceuticals Inc.

47,215 CAD14SEDI ↗

3,500 shares@ CA$13.495.3% of flowCommon SharesTSXSEDI:4479657

◇

Harold Morton Wolkin

4 - Director of IssuerExecutives24 Mar 2025Cipher Pharmaceuticals Inc.

17,710 CAD13SEDI ↗

3,500 shares@ CA$5.062.0% of flowCommon SharesTSXSEDI:4479651

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives19 Mar 2025Cipher Pharmaceuticals Inc.

4,669 CAD11SEDI ↗

391 shares@ CA$11.940.5% of flowCommon SharesTSXSEDI:4476724

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives14 Feb 2025Cipher Pharmaceuticals Inc.

4,680 CAD11SEDI ↗

360 shares@ CA$13.000.6% of flowCommon SharesTSXSEDI:4454254

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Jan 2025Cipher Pharmaceuticals Inc.

4,675 CAD11SEDI ↗

338 shares@ CA$13.830.6% of flowCommon SharesTSXSEDI:4438093

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives17 Jun 2024Cipher Pharmaceuticals Inc.

4,656 CAD17SEDI ↗

537 shares@ CA$8.670.4% of flowCommon SharesTSXSEDI:4332035

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives16 May 2024Cipher Pharmaceuticals Inc.

4,657 CAD17SEDI ↗

518 shares@ CA$8.990.4% of flowCommon SharesTSXSEDI:4315161

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Apr 2024Cipher Pharmaceuticals Inc.

4,659 CAD17SEDI ↗

527 shares@ CA$8.840.4% of flowCommon SharesTSXSEDI:4301041

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives18 Mar 2024Cipher Pharmaceuticals Inc.

4,660 CAD17SEDI ↗

606 shares@ CA$7.690.4% of flowCommon SharesTSXSEDI:4281508

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives16 Feb 2024Cipher Pharmaceuticals Inc.

4,656 CAD17SEDI ↗

667 shares@ CA$6.980.5% of flowCommon SharesTSXSEDI:4260711

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Jan 2024Cipher Pharmaceuticals Inc.

4,659 CAD17SEDI ↗

795 shares@ CA$5.860.5% of flowCommon SharesTSXSEDI:4245372

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives18 Dec 2023Cipher Pharmaceuticals Inc.

4,592 CAD15SEDI ↗

713 shares@ CA$6.4438.1% of flowCommon SharesTSXSEDI:4228752

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 Aug 2023Cipher Pharmaceuticals Inc.

4,615 CAD17SEDI ↗

1,330 shares@ CA$3.470.4% of flowCommon SharesTSXSEDI:4170813

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives14 Jul 2023Cipher Pharmaceuticals Inc.

4,635 CAD17SEDI ↗

1,332 shares@ CA$3.480.4% of flowCommon SharesTSXSEDI:4159652

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives14 Jun 2023Cipher Pharmaceuticals Inc.

4,587 CAD17SEDI ↗

1,207 shares@ CA$3.800.4% of flowCommon SharesTSXSEDI:4144503

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives15 May 2023Cipher Pharmaceuticals Inc.

5,264 CAD17SEDI ↗

1,562 shares@ CA$3.370.5% of flowCommon SharesTSXSEDI:4128747

◆

Harold Morton Wolkin

4 - Director of IssuerExecutives18 Apr 2023Cipher Pharmaceuticals Inc.

4,012 CAD17SEDI ↗

1,180 shares@ CA$3.400.4% of flowCommon SharesTSXSEDI:4118987

◇

Harold Morton Wolkin

4 - Director of IssuerExecutives29 Mar 2023Cipher Pharmaceuticals Inc.

28,125 CAD17SEDI ↗

7,500 shares@ CA$3.752.5% of flowCommon SharesTSXSEDI:4113686

25 of 97 declarations